Grupo de Terapia Celular y Medicina Regenerativa, Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña (CHUAC), 15006-A, Coruña, Spain.
Departamento de Fisioterapia, Ciencias Biomédicas y Medicina, Facultad de Ciencias de la Salud, Universidad de A Coruña (UDC), As Xubias, 15006-A, Coruña, Spain.
Stem Cell Res Ther. 2020 Jan 3;11(1):13. doi: 10.1186/s13287-019-1534-0.
This study assessed whether mesenchymal stem cell (MSC)-derived extracellular vesicles influenced ageing and pluripotency markers in cell cultures where they are added.
MSC-derived extracellular vesicles from old and young rat bone marrows were isolated by ultracentrifugation and were characterised by western blotting, nanoparticle tracking analysis (NTA) and transmission electron microscopy (TEM). They were added to young and old MSC cultures. Real-time quantitative reverse transcription polymerase chain reactions and western blot analysis were performed to check the markers of ageing (vinculin and lamin A), pluripotency markers (Nanog and Oct4) and components of the mTOR signalling pathway (Rictor, Raptor, AKT and mTOR) in these cell populations. Subsequently, microRNA (miR)-188-3p expression was transiently inhibited in young MSCs to demonstrate the influence of mTOR2 on MSC ageing.
Incubation with young MSC-derived extracellular vesicles decreased the levels of ageing markers and components of the mTOR pathway and increased the pluripotency markers from old MSC populations. By contrast, incubation of young MSCs with old MSC-derived extracellular vesicles generated the reverse effects. Inhibition of miR-188-3p expression in young MSCs produced extracellular vesicles that when incubated with old MSCs produced an increase in the levels of Rictor, as well as a decrease of phosphor-AKT, as indicated by a significant decrease in beta-galactosidase staining.
MSC-derived extracellular vesicles affected the behaviour of MSC cultures, based on their composition, which could be modified in vitro. These experiments represented the basis for the development of new therapies against ageing-associated diseases using MSC-derived extracellular vesicles.
本研究评估了间充质干细胞(MSC)衍生的细胞外囊泡(EVs)在添加到细胞培养物中时是否会影响衰老和多能性标志物。
通过超速离心从老年和年轻大鼠骨髓中分离 MSC 衍生的细胞外囊泡,并通过 Western blot、纳米颗粒跟踪分析(NTA)和透射电子显微镜(TEM)进行表征。将它们添加到年轻和老年 MSC 培养物中。通过实时定量逆转录聚合酶链反应和 Western blot 分析,检查这些细胞群体中的衰老标志物(波形蛋白和核纤层蛋白 A)、多能性标志物(Nanog 和 Oct4)和 mTOR 信号通路成分(Rictor、Raptor、AKT 和 mTOR)。随后,在年轻 MSC 中转染 miR-188-3p 的瞬时抑制实验,以证明 mTOR2 对 MSC 衰老的影响。
孵育年轻 MSC 衍生的细胞外囊泡降低了老年 MSC 群体中衰老标志物和 mTOR 通路成分的水平,并增加了多能性标志物的表达。相反,年轻 MSC 与老年 MSC 衍生的细胞外囊泡孵育产生了相反的效果。在年轻 MSC 中抑制 miR-188-3p 的表达产生了细胞外囊泡,当与老年 MSC 共孵育时,Rictor 的水平增加,phosphor-AKT 的水平降低,β-半乳糖苷酶染色明显减少,表明 AKT 磷酸化减少。
基于细胞外囊泡的组成,MSC 衍生的细胞外囊泡影响 MSC 培养物的行为,这种影响可以在体外进行修饰。这些实验为使用 MSC 衍生的细胞外囊泡开发针对与衰老相关疾病的新疗法奠定了基础。